Neurological biomarkers are measurable biological indicators found in bodily fluids or brain scans that provide information about the presence, progression, or risk of neurological disorders such as Alzheimer’s disease or Parkinson’s disease. They aid in diagnosis, monitoring, and research, offering insights into neurological health and disease-related changes. In terms of revenue, the global neurological biomarkers market was worth US$ 7.11 Bn in 2022, anticipated to witness CAGR of 11.5% during 2023 – 2031.

Global Neurological Biomarkers Market Revenue & Forecast, (US$ Million), 2015 – 2031

Trends in the Global Neurological Biomarkers Market

Currently, advancements in brain imaging technologies are revolutionizing the neurological biomarkers market. Cutting-edge techniques like functional MRI (fMRI) and positron emission tomography (PET) scans are enabling real-time observation of neurological processes. This continuous development enhances our ability to identify and measure biomarkers, allowing for earlier disease detection and personalized treatment plans. The ongoing refinement of these imaging modalities is bolstering their role in neuroscience research and clinical applications, further propelling the market’s growth.

Report Coverage and Deliverables: 

Precision medicine is playing an increasingly vital role in shaping the neurological biomarkers market. The trend involves tailoring treatments based on individual patient characteristics, including biomarker profiles. Currently, healthcare providers are integrating genetic and molecular biomarker data into clinical decision-making processes. This tailored approach enhances treatment efficacy, thereby reducing adverse effects, which in turn will improve patient outcomes. With ongoing research and the growing availability of biomarker-based therapies, precision medicine continues to be a driving force in the neurological biomarkers sector, promising more effective treatments for patients.

Metabolomic segment has gained popularity in recent years and is anticipated to be the fastest growing segment in the global neurological biomarkers market during the forecast period. This growth can be attributed to its ability to capture dynamic metabolic changes associated with neurological disorders. Metabolomics, aided by advanced spectroscopy and analytical techniques, enables the identification of small molecule metabolites in bodily fluids.

This approach has revealed distinct metabolic profiles in conditions like multiple sclerosis and Parkinson’s disease. A study published in the journal ‘Frontiers in Neurology’ reported significant alterations in metabolomic profiles of patients with neurodegenerative disorders. The ability to detect subtle metabolic variations is positioning metabolomic biomarkers as a vital tool for early diagnosis, disease progression monitoring, and the development of targeted therapies, fueling their rapid growth in the market.

Alzheimer’s disease segment had the highest share in the global neurological biomarkers market in 2022. This is primarily attributed to its staggering prevalence and socioeconomic impact. Alzheimer’s disease has affected millions of people worldwide, accounting for the majority of neurological disorders. According to the study, nearly 50 million people were living with dementia in 2020, with Alzheimer’s constituting the majority of cases. This prevalence drives substantial research and investment in biomarker development for early detection and intervention. Prominent biomarkers, such as amyloid-beta and tau proteins, have gained prominence. The urgent need for effective Alzheimer’s diagnostics and therapeutics underscores its dominant position in the neurological biomarkers landscape, fostering innovation and collaboration in the healthcare industry.

Asia Pacific is expected to witness the highest growth rate in the neurological biomarkers market during the forecast period. The growth is driven by a surge in neurological disorders. Statistics indicate a substantial increase in neurological disease incidence, with millions affected. This growth is driven by factors such as aging populations, urbanization, and lifestyle changes in countries like China and India. Increasing healthcare expenditure and rising awareness of early diagnosis are fostering biomarker research and development. Collaboration with international partners and the establishment of biomarker-related databases and initiatives signify the region’s commitment to advancing neurological biomarker adoption. The Asia Pacific’s rapid economic growth and healthcare evolution underpin its accelerated expansion in this market.

Competitive Landscape

Some of the players operating in the neurological biomarkers market are

• Abbott
• BIOMERIEUX
• Bio-Rad Laboratories, Inc.
• Johnson & Johnson Services, Inc.
• Merck KGaA
• Quanterix
• Rules-Based Medicine
• Thermo Fisher Scientific Inc.
• Other Industry Participants

Report Summary of Global Neurological Biomarkers Market

Global Neurological Biomarkers Market

By Type

• Genomic
• Proteomic
• Metabolomic
• Imaging
• Others

By Application

• Alzheimer’s Disease
• Parkinson’s Disease
• Multiple Sclerosis
• Autism Spectrum Disorder
• Others

By End Use

• Hospital & Hospital Laboratories
• Independent Clinical Diagnostic Centers
• Research Organizations And Others

By Region

• North America (U.S., Canada, Mexico, Rest of North America)
• Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe)
• Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific)
• Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
• Latin America (Brazil, Argentina, Rest of Latin America)

Table of Contents

.

.

**Exclusive for Multi-User and Enterprise User.

.

Global Neurological Biomarkers Market Segmentation

By Type

By Application

By End Use

By Region

**Note: The report covers cross-segmentation analysis by region further into countries

.

The Niche Research approach encompasses both primary and secondary research methods to provide comprehensive insights. While primary research is the cornerstone of our studies, we also incorporate secondary research sources such as company annual reports, premium industry databases, press releases, industry journals, and white papers.

Within our primary research, we actively engage with various industry stakeholders, conducting paid interviews and surveys. Our meticulous analysis extends to every market participant in major countries, allowing us to thoroughly examine their portfolios, calculate market shares, and segment revenues.

Our data collection primarily focuses on individual countries within our research scope, enabling us to estimate regional market sizes. Typically, we employ a bottom-up approach, meticulously tracking trends in different countries. We analyze growth drivers, constraints, technological innovations, and opportunities for each country, ultimately arriving at regional figures.Our process begins by examining the growth prospects of each country. Building upon these insights, we project growth and trends for the entire region. Finally, we utilize our proprietary model to refine estimations and forecasts.

Our data validation standards are integral to ensuring the reliability and accuracy of our research findings. Here’s a breakdown of our data validation processes and the stakeholders we engage with during our primary research:

• Supply Side Analysis: We initiate a supply side analysis by directly contacting market participants, through telephonic interviews and questionnaires containing both open-ended and close-ended questions. We gather information on their portfolios, segment revenues, developments, and growth strategies.
• Demand Side Analysis: To gain insights into adoption trends and consumer preferences, we reach out to target customers and users (non-vendors). This information forms a vital part of the qualitative analysis section of our reports, covering market dynamics, adoption trends, consumer behavior, spending patterns, and other related aspects.
• Consultant Insights: We tap into the expertise of our partner consultants from around the world to obtain their unique viewpoints and perspectives. Their insights contribute to a well-rounded understanding of the markets under investigation.
• In-House Validation: To ensure data accuracy and reliability, we conduct cross-validation of data points and information through our in-house team of consultants and utilize advanced data modeling tools for thorough verification.

The forecasts we provide are based on a comprehensive assessment of various factors, including:

• Market Trends and Past Performance (Last Five Years): We accurately analyze market trends and performance data from preceding five years to identify historical patterns and understand the market’s evolution.
• Historical Performance and Growth of Market Participants: We assess the historical performance and growth trajectories of key market participants. This analysis provides insights into the competitive landscape and individual company strategies.
• Market Determinants Impact Analysis (Next Eight Years): We conduct a rigorous analysis of the factors that are projected to influence the market over the next eight years. This includes assessing both internal and external determinants that can shape market dynamics.
• Drivers and Challenges for the Forecast Period:Identify the factors expected to drive market growth during the forecast period, as well as the challenges that the industry may face. This analysis aids in deriving an accurate growth rate projection.
• New Acquisitions, Collaborations, or Partnerships: We keep a close watch on any new acquisitions, collaborations, or partnerships within the industry. These developments can have a significant impact on market dynamics and competitiveness.
• Macro and Micro Factors Analysis:A thorough examination of both macro-level factors (e.g., economic trends, regulatory changes) and micro-level factors (e.g., technological advancements, consumer preferences) that may influence the market during the forecast period.
• End-User Sentiment Analysis: To understand the market from the end-user perspective, we conduct sentiment analysis. This involves assessing the sentiment, preferences, and feedback of the end-users, which can provide valuable insights into market trends.
• Perspective of Primary Participants: Insights gathered directly from primary research participants play a crucial role in shaping our forecasts. Their perspectives and experiences provide valuable qualitative data.
• Year-on-Year Growth Trend: We utilize a year-on-year growth trend based on historical market growth and expected future trends. This helps in formulating our growth projections, aligning them with the market’s historical performance.

Research process adopted by TNR involves multiple stages, including data collection, validation, quality checks, and presentation. It’s crucial that the data and information we provide add value to your existing market understanding and expertise. We have also established partnerships with business consulting, research, and survey organizations across regions and globally to collaborate on regional analysis and data validation, ensuring the highest level of accuracy and reliability in our reports.